Literature DB >> 14645554

Varied immunity generated in mice by DNA vaccines with large and small hepatitis delta antigens.

Yi-Hsiang Huang1, Jaw-Ching Wu, Sheng-Chieh Hsu, Wan-Jr Syu.   

Abstract

Whether the hepatitis delta virus (HDV) DNA vaccine can induce anti-HDV antibodies has been debatable. The role of the isoprenylated motif of hepatitis delta antigens (HDAg) in the generation of immune responses following DNA-based immunization has never been studied. Plasmids p2577L, encoding large HDAg (L-HDAg), p2577S, expressing small HDAg (S-HDAg), and p25L-211S, encoding a mutant form of L-HDAg with a cysteine-to-serine mutation at codon 211, were constructed in this study. Mice were intramuscularly injected with the plasmids. The anti-HDV antibody titers, T-cell proliferation responses, T-helper responses, and HDV-specific, gamma interferon (IFN-gamma)-producing CD8(+) T cells were analyzed. Animals immunized with p2577S showed a strong anti-HDV antibody response. Conversely, only a low titer of anti-HDV antibodies was detected in mice immunized with p2577L. Epitope mapping revealed that the anti-HDV antibodies generated by p2577L vaccination hardly reacted with epitope amino acids 174 to 194, located at the C terminus of S-HDAg. All of the HDAg-encoding plasmids could induce significant T-cell proliferation responses and generate Th1 responses and HDV-specific, IFN-gamma-producing CD8(+) T cells. In conclusion, HDAg-specific antibodies definitely exist following DNA vaccination. The magnitudes of the humoral immune responses generated by L-HDAg- and S-HDAg-encoding DNA vaccines are different. The isoprenylated motif can mask epitope amino acids 174 to 195 of HDAg but does not interfere with cellular immunity following DNA-based immunization. These findings are important for the choice of a candidate HDV DNA vaccine in the future.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645554      PMCID: PMC296071          DOI: 10.1128/jvi.77.24.12980-12985.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Correlation of serum delta RNA with clinical course of acute hepatitis delta virus superinfection in Taiwan: a longitudinal study.

Authors:  J C Wu; S D Lee; S Govindarajan; T W Kung; Y T Tsai; K J Lo; L P Ting
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

2.  Identification of a prenylation site in delta virus large antigen.

Authors:  J S Glenn; J A Watson; C M Havel; J M White
Journal:  Science       Date:  1992-05-29       Impact factor: 47.728

3.  Immunogenic domains of hepatitis delta virus antigen: peptide mapping of epitopes recognized by human and woodchuck antibodies.

Authors:  J G Wang; R W Jansen; E A Brown; S M Lemon
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

4.  A unique conformation at the carboxyl terminus of the small hepatitis delta antigen revealed by a specific monoclonal antibody.

Authors:  S B Hwang; M M Lai
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

5.  Immunohistochemical differentiation of hepatitis D virus genotypes.

Authors:  S C Hsu; W J Syu; L T Ting; J C Wu
Journal:  Hepatology       Date:  2000-11       Impact factor: 17.425

6.  Recombination of hepatitis D virus RNA sequences and its implications.

Authors:  J C Wu; T Y Chiang; W K Shiue; S Y Wang; I J Sheen; Y H Huang; W J Syu
Journal:  Mol Biol Evol       Date:  1999-11       Impact factor: 16.240

7.  Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction.

Authors:  J C Wu; T Z Chen; Y S Huang; F S Yen; L T Ting; W Y Sheng; S H Tsay; S D Lee
Journal:  Gastroenterology       Date:  1995-03       Impact factor: 22.682

8.  Treatment of chronic hepatitis D with interferon alfa-2a.

Authors:  P Farci; A Mandas; A Coiana; M E Lai; V Desmet; P Van Eyken; Y Gibo; L Caruso; S Scaccabarozzi; D Criscuolo
Journal:  N Engl J Med       Date:  1994-01-13       Impact factor: 91.245

9.  Partial control of hepatitis delta virus superinfection by immunisation of woodchucks (Marmota monax) with hepatitis delta antigen expressed by a recombinant vaccinia or baculovirus.

Authors:  P Karayiannis; J Saldanha; A M Jackson; S Luther; R Goldin; J Monjardino; H C Thomas
Journal:  J Med Virol       Date:  1993-11       Impact factor: 2.327

10.  Isoprenylation of large hepatitis delta antigen is necessary but not sufficient for hepatitis delta virus assembly.

Authors:  C Z Lee; P J Chen; M M Lai; D S Chen
Journal:  Virology       Date:  1994-02-15       Impact factor: 3.616

View more
  5 in total

1.  Different sources of "help" facilitate the antibody response to hepatitis D virus delta antigen.

Authors:  Peter Seizer; Petra Riedl; Jörg Reimann; Reinhold Schirmbeck
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

2.  Protein-peptide arrays for detection of specific anti-hepatitis D virus (HDV) genotype 1, 6, and 8 antibodies among HDV-infected patients by surface plasmon resonance imaging.

Authors:  Marie-Bernadette Villiers; Jean-Claude Cortay; Sandra Cortès; Bénédicte Bloquel; Ségolène Brichler; Carine Brakha; Alan Kay; Nisrine Falah; Fabien Zoulim; Christophe Marquette; Patrice N Marche; Paul Dény
Journal:  J Clin Microbiol       Date:  2015-01-28       Impact factor: 5.948

3.  Positive selection of hepatitis delta antigen in chronic hepatitis D patients.

Authors:  Shen-Yung Wang; Jaw-Ching Wu; Tzen-Yuh Chiang; Yi-Hsiang Huang; Chien-Wei Su; I-Jane Sheen
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

4.  Prime/boost immunization with DNA and adenoviral vectors protects from hepatitis D virus (HDV) infection after simultaneous infection with HDV and woodchuck hepatitis virus.

Authors:  Melanie Fiedler; Anna Kosinska; Alexandra Schumann; Olena Brovko; Andreas Walker; Mengji Lu; Lena Johrden; Anja Mayer; Oliver Wildner; Michael Roggendorf
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

Review 5.  Therapeutic Strategies and New Intervention Points in Chronic Hepatitis Delta Virus Infection.

Authors:  Zhimin Guo; Thomas King
Journal:  Int J Mol Sci       Date:  2015-08-18       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.